Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study Evaluating Haploidentical Allogeneic Transplantation Using the CliniMACS System in Patients With Advanced Hematologic Malignancies

NCT00185679 is registered in ClinicalTrials.gov with Ginna Laport as lead sponsor.

NCT NCT00185679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00185679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study Evaluating Haploidentical Allogeneic Transplantation Using the CliniMACS System in Patients With Advanced Hematologic Malignancies
Lead sponsor
Ginna Laport
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2001
Completion date
February 28, 2010
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myelogenous leukemia (aml) - relapsed, primary refractory disease or poor risk factors, chronic lymphocytic leukemia (cll) - refractory, chronic myelogenous leukemia (cml) - accelerated or second chronic phase, myelodysplastic syndrome (mds) - high and intermediate risk, non-hodgkin's lymphoma (nhl)